tldnr:<p>[quote]<p>> as on the 27 controlled trials available in January 2021, 15 of which were randomized controlled trials (RCT's), the preferred trial of the World Health Organization, U.S. National Institutes of Health, and the European Medicines Agency. Consistent with numerous meta-analyses of ivermectin RCT's since published by expert panels from the UK, Italy, Spain, and Japan, they found large, statistically significant reduction in mortality, time to recovery and viral clearance in COVID-19 patients treated with ivermectin.<p>> To evaluate the efficacy of ivermectin in preventing COVID-19, 3 RCT's and 5 observational controlled trial's including almost 2,500 patients all reported that ivermectin significantly reduces the risk of contracting COVID-19 when used regularly.<p>Many regions around the world now recognize that ivermectin is a powerful prophylaxis and treatment for COVID-19. South Africa, Zimbabwe, Slovakia, Czech Republic, Mexico, and now, India, have approved the drug for use by medical professionals. The results as seen in this latest study demonstrate that the ivermectin distribution campaigns repeatedly led to "rapid population-wide decreases in morbidity and mortality."<p>> The published research can be found in the latest edition of the American Journal of Therapeutics: <a href="https://journals.lww.com/americantherapeutics/Fulltext/2021/00000/Review_of_the_Emerging_Evidence_Demonstrating_the.4.aspx" rel="nofollow">https://journals.lww.com/americantherapeutics/Fulltext/2021/...</a><p>[/quote]